Melatonin inhibition of nicotine-stimulated dopamine release in PC12 cells

Brain Research

Volumn 966, Issue 1, 2003, Pages 95-102

  Schiller, Edward D ^a   Champney, Thomas H ^a   Reiter, Cindy K ^a   Dohrman, Douglas P ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Dopamine; Melatonin; Nicotine; PC12; Pertussis toxin

Indexed keywords

MELATONIN; MELATONIN RECEPTOR; NICOTINE; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL ACTIVITY; CELL INTERACTION; CONTROLLED STUDY; DOPAMINE RELEASE; HORMONE ACTION; HORMONE INHIBITION; LONG TERM EXPOSURE; NERVE CELL; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RAT;

ANIMALS; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MELATONIN; NICOTINE; PC12 CELLS; PERTUSSIS TOXIN; RATS;

EID: 0037436420     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)04200-2     Document Type: Article

References (29)

1. Ayar A., Martin D.J., Ozcan M., Kelestimur H. Melatonin inhibits high voltage activated calcium currents in cultured rat dorsal root ganglion neurones. Neurosci. Lett. 313:2001;73-77.
2. Boatright J.H., Rubim N.M., Iuvone P.M. Regulation of endogenous dopamine release in amphibian retina by melatonin: the role of GABA. Vis. Neurosci. 11:1994;1013-1018.
3. Cardinali D.P., Nagle C.A., Freire F., Rosner J.M. Effects of melatonin on neurotransmitter uptake and release by synaptosome-rich homogenates of the rat hypothalamus. Neuroendocrinology. 18:1975;72-85.
4. Carlson L.L., Weaver D.R., Reppert S.M. Melatonin signal transduction in hamster brain: inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein. Endocrinology. 125:1989;2670-2676.
5. Ceraulo L., Ferrugia M., Tesoriere L., Segreto S., Livrea M.A., Turco Liveri V. Interactions of melatonin with membrane models: portioning of melatonin in AOT and lecithin reversed micelles. J. Pineal Res. 26:1999;108-112.
6. Champney T.H., Hanneman W.H., Nichols M.A. gamma-Aminobutyric acid, catecholamine and indoleamine determinations from the same brain region by high performance liquid chromatography with electrochemical detection. J. Chromatog. Biomed. Applic. 579:1992;334-339.
7. Chan A.S.L., Lai F.P.L., Voyno-Yasenetskaya T.A., Stanbridge E.J., Wong Y.H. Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and-insensitive G proteins. Cell. Signal. 14:2002;249-257.
8. Conforti L., Kobayashi S., Beitner-Johnson D., Conrad P.W., Freeman T., Millhorn D.E. Regulation of gene expression and secretory functions in oxygen-sensing pheochromocytoma cells. Respir. Physiol. 115:1999;249-260.
9. Dani J.A., Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron. 16:1996;905-908.
10. Date I., Shingo T., Yoshida H., Fujiwara K., Kobayashi K., Ohmoto T. Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: long-term primate study. Cell Transplant. 9:2000;705-709.
11. Dubocovich M.L. Melatonin is a potent modulator of dopamine release in the retina. Nature. 306:1983;782-784.
12. Eilers H., Schaeffer E., Bickler P.E., Forsayeth J.R. Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism. Molec. Pharmacol. 52:1997;1105-1112.
13. Gaddnas H., Pietila K., Piepponen P., Ahtee L. Enhanced motor activity and brain dopamine turnover in mice during long-term nicotine administration in the drinking water. Pharmacol. Biochem. Behav. 70:2001;497-503.
14. Gassen M., Gross A., Youdim M.B. Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine. Move. Disord. 13:1998;661-667.
15. Khaldy H., Leon J., Escames G., Bikjdaouene L., Garcia J.J., Acuna-Castroviejo D. Circadian rhythms of dopamine and dihydroxyphenylacetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology. 75:2002;201-208.
16. Lukas R.J. Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line. J. Neurochem. 56:1991;1134-1145.
17. Nakamura K., Katoh H., Ichikawa A., Negishi M. Inhibition of dopamine release by prostaglandin EP3 receptor via pertussis toxin-sensitive and-insensitive pathways in PC12 cells. J. Neurochem. 71:1998;646-652.
18. Nakamura S., Takahashi T., Yamashita H., Kawakami H. Nicotinic acetylcholine receptors and neurodegenerative disease. Alcohol. 24:2001;79-81.
19. Nowak J.Z., Kazula A., Golembiowska K. Melatonin increases serotonin N-acetyltransferase activity and decreases dopamine synthesis in light-exposed chick retina: in vivo evidence supporting melatonin-dopamine interaction in retina. J. Neurochem. 59:1992;1499-1505.
20. Park J.W., Youn Y.C., Kwon O.S., Jang Y.Y., Han E.S., Lee C.S. Protective effect of serotonin on 6-hydroxydopamine- and dopamine-induced oxidative damage of brain mitochondria and synaptosomes and PC12 cells. Neurochem. Intl. 40:2002;223-233.
21. Reiter R.J., Tan D.X., Manchester L.C., El-Sawi M.R. Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann. NY Acad. Sci. 959:2002;238-250.
22. Roth J.A., Rabin R., Agnello K. Melatonin suppression of PC12 cell growth and death. Brain Res. 768:1997;63-70.
23. Roth J.A., Rosenblatt T., Lis A., Buccelli R. Melatonin-induced suppression of PC12 cell growth is mediated by its Gi coupled transmembrane receptors. Brain Res. 919:2001;139-146.
24. Shimazaki Y., Nishiki T., Omori A., Sekiguchi M., Kamata Y., Kozaki S., Takahashi M. Phosphorylation of 25-kDa synaptosome-associated protein. J. Biol. Chem. 271:1996;14548-14553.
25. Shoji-Kasai Y., Morishima M., Kuwahara R., Kondo S., Itakura M., Takahashi M. Establishment of variant PC12 subclones deficient in stimulation-secretion coupling. Biochim. Biophys. Acta. 1499:2001;180-190.
26. Weatherspoon J.K., Werling L.L. Modulation of amphetamine-stimulated [3H]dopamine release from rat pheochromocytoma (PC12) cells by sigma type 2 receptors. J. Pharm. Exp. Therap. 289:1999;278-284.
27. Weber B., Schliker E. Modulation of dopamine release in the guinea-pig retina by G(i)- but not by G(s)- or G(q)-protein coupled receptors. Fund. Clin. Pharmacol. 15:2001;393-400.
28. Zhdanova I.V., Piotrovskaya V.R. Melatonin treatment attenuates symptoms of acute nicotine withdrawal in humans. Pharmacol. Biochem. Behav. 67:2000;131-135.
29. Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell. Molec. Neurobiol. 21:2001;605-616.